International Alliances as Sources of Capital: Evidence from the Biotechnology Industry

This study empirically tested the relationship between three signaling mechanisms (scientific capabilities, firm location and top management team international experience) and the amount of capital raised through international strategic alliances. The number of patents held by the firm, firm location and the number of products in stage III of development were found to be significant. Implications for managers and researchers are discussed.